Company Filing History:
8 out of 790 
6 out of 8 
1 out of 61 
Years Active: 2010-2020
Title: **Innovator Spotlight: Steven R. Ledbetter**
Introduction
Steven R. Ledbetter, based in Westborough, MA, has made significant strides in the field of biotechnology as an accomplished inventor. With a portfolio of 8 patents, he has been instrumental in developing innovative solutions, particularly in the area of antibody technology. His work has profound implications for the treatment of various diseases, showcasing the impact of his inventions in the scientific community.
Latest Patents
Steven's latest patents focus on antibody molecules targeting Transforming Growth Factor beta (TGF-β). Specifically, he has developed 'pan-specific' antibody molecules that bind and neutralize TGF-β1, TGF-β2, and TGF-β3. These antibodies can be whole antibody forms, like IgG (e.g., IgG1 or IgG4), or fragments such as scFv, Fab, and dAb. The potential uses of these antibody molecules span across various therapeutic applications, highlighting the innovation Steven brings to the field.
Career Highlights
Throughout his career, Steven has contributed to the advancement of biotechnology while working with reputable organizations such as Genzyme Corporation and Optein, Inc. His experience at these companies has enriched his understanding of the industry and helped refine his innovative concepts, allowing him to create patented technologies that pave the way for future developments.
Collaborations
Steven has collaborated with esteemed colleagues like Celia Patricia Hart and Robert G. Holgate. These partnerships have fostered an environment of shared knowledge and innovation, enabling him to advance his research and patent new technologies that could have significant health benefits.
Conclusion
In summary, Steven R. Ledbetter is an influential inventor whose work with antibodies to TGF-β demonstrates the potential for significant advancements in medical treatments. His extensive patent portfolio and collaborative career underscore his dedication to innovation in biotechnology, marking him as a notable figure in the scientific community. As he continues to push the boundaries of research and development, his contributions are sure to leave a lasting impact on the industry.